DOCSLIB.ORG

Mouse P4ha1 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse P4ha1 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse P4ha1 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a P4ha1 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The P4ha1 gene (NCBI Reference Sequence: NM_011030 ; Ensembl: ENSMUSG00000019916 ) is located on Mouse chromosome 10. 15 exons are identified, with the ATG start codon in exon 2 and the TGA stop codon in exon 15 (Transcript: ENSMUST00000009789). Exon 3 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse P4ha1 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-417A11 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a null mutation display embryonic lethality during organogenesis, capillary ruptures, and impaired basement membrane formation. Exon 3 starts from about 4.81% of the coding region. The knockout of Exon 3 will result in frameshift of the gene. The size of intron 2 for 5'-loxP site insertion: 2139 bp, and the size of intron 3 for 3'-loxP site insertion: 3291 bp. The size of effective cKO region: ~597 bp. The cKO region does not have any other known gene. Page 1 of 7 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 2 3 15 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse P4ha1 Homology arm cKO region loxP site Page 2 of 7 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7097bp) | A(29.67% 2106) | C(19.15% 1359) | T(29.76% 2112) | G(21.42% 1520) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 7 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN -------------------------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr10 + 59336047 59339046 3000 browser details YourSeq 249 1258 2385 3000 89.4% chr5 - 29445662 29729927 284266 browser details YourSeq 168 2099 2826 3000 76.6% chr16 + 56128358 56128908 551 browser details YourSeq 163 916 1440 3000 84.0% chr10 - 24636491 24636909 419 browser details YourSeq 162 1791 2619 3000 78.5% chr13 + 3697953 3698520 568 browser details YourSeq 161 1234 1441 3000 89.9% chr7 - 117680775 117680975 201 browser details YourSeq 160 826 1441 3000 84.4% chr5 - 122413684 122413883 200 browser details YourSeq 160 1255 1441 3000 93.1% chr1 + 182154876 182155066 191 browser details YourSeq 159 1254 1439 3000 93.0% chr9 - 110882877 110883233 357 browser details YourSeq 157 1234 1441 3000 89.1% chrX - 104138473 104138677 205 browser details YourSeq 157 1232 1441 3000 86.2% chr11 + 105440459 105440658 200 browser details YourSeq 156 1254 1441 3000 91.5% chr7 - 100585378 100585565 188 browser details YourSeq 156 1253 1441 3000 90.9% chr12 - 3757583 3757769 187 browser details YourSeq 156 1253 1446 3000 93.9% chr11 - 115391147 115391649 503 browser details YourSeq 155 1255 1441 3000 93.9% chr1 - 181036974 181037173 200 browser details YourSeq 155 1233 1435 3000 87.2% chr9 + 86041864 86042062 199 browser details YourSeq 154 1256 1441 3000 93.3% chr8 + 105581961 105797174 215214 browser details YourSeq 154 1250 1441 3000 89.2% chr2 + 165892164 165892351 188 browser details YourSeq 153 1236 1442 3000 87.6% chr5 - 33263228 33263425 198 browser details YourSeq 153 1255 1485 3000 87.7% chr2 + 170237792 170237998 207 Note: The 3000 bp section upstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr10 + 59339644 59342643 3000 browser details YourSeq 232 1189 1649 3000 87.7% chr18 + 90228294 90229111 818 browser details YourSeq 231 1171 1647 3000 87.9% chrX - 68737333 68738149 817 browser details YourSeq 231 1076 1514 3000 82.7% chr14 + 60314149 60314593 445 browser details YourSeq 230 1186 1774 3000 87.9% chr16 + 30110064 30110784 721 browser details YourSeq 228 1075 1849 3000 90.8% chr14 + 20274251 20275164 914 browser details YourSeq 225 1073 1622 3000 84.7% chr12 + 98598194 98599091 898 browser details YourSeq 223 1077 1646 3000 88.3% chr15 - 16840456 16996618 156163 browser details YourSeq 222 1185 1807 3000 87.5% chr5 - 129376426 129377249 824 browser details YourSeq 219 1176 1788 3000 89.1% chr6 + 137107361 137108227 867 browser details YourSeq 213 1080 1514 3000 82.6% chr7 + 99053002 99053438 437 browser details YourSeq 213 1184 1505 3000 89.4% chr15 + 37806655 37807039 385 browser details YourSeq 211 1079 1723 3000 86.1% chr7 - 38176466 38177412 947 browser details YourSeq 205 1187 1658 3000 86.8% chr9 - 54578363 54579061 699 browser details YourSeq 204 1192 1536 3000 86.3% chr3 + 42100798 42101137 340 browser details YourSeq 204 1184 1534 3000 87.2% chr13 + 21606514 21606873 360 browser details YourSeq 203 1080 1536 3000 88.6% chr6 - 140747322 140747812 491 browser details YourSeq 203 1185 1669 3000 84.7% chr11 + 81481514 81482234 721 browser details YourSeq 201 1073 1651 3000 86.4% chr9 - 75691421 75692241 821 browser details YourSeq 201 1209 1811 3000 85.1% chr13 + 102475504 102476308 805 Note: The 3000 bp section downstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. Page 4 of 7 https://www.alphaknockout.com Gene and protein information: P4ha1 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide [ Mus musculus (house mouse) ] Gene ID: 18451, updated on 21-Oct-2019 Gene summary Official Symbol P4ha1 provided by MGI Official Full Name procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide provided by MGI Primary source MGI:MGI:97463 See related Ensembl:ENSMUSG00000019916 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as P4ha; AL022634 Expression Ubiquitous expression in limb E14.5 (RPKM 22.1), placenta adult (RPKM 17.9) and 25 other tissues See more Orthologs human all Genomic context Location: 10; 10 B4 See P4ha1 in Genome Data Viewer Exon count: 16 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 10 NC_000076.6 (59323197..59373304) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 10 NC_000076.5 (58786044..58836052) Chromosome 10 - NC_000076.6 Page 5 of 7 https://www.alphaknockout.com Transcript information: This gene has 3 transcripts Gene: P4ha1 ENSMUSG00000019916 Description procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide [Source:MGI Symbol;Acc:MGI:97463] Gene Synonyms P4ha Location Chromosome 10: 59,323,296-59,373,304 forward strand. GRCm38:CM001003.2 About this gene This gene has 3 transcripts (splice variants), 207 orthologues, 3 paralogues, is a member of 1 Ensembl protein family and is associated with 8 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags P4ha1-201 ENSMUST00000009789.14 4043 534aa ENSMUSP00000009789.8 Protein coding CCDS23863 Q60715 TSL:1 GENCODE basic APPRIS P3 P4ha1-203 ENSMUST00000105466.2 2918 534aa ENSMUSP00000101106.2 Protein coding CCDS83698 Q60715 TSL:1 GENCODE basic APPRIS ALT1 P4ha1-202 ENSMUST00000092512.10 2387 454aa ENSMUSP00000090170.4 Protein coding CCDS83699 E9Q7B0 TSL:1 GENCODE basic 70.01 kb Forward strand Genes (Comprehensive set... P4ha1-201 >protein coding P4ha1-202 >protein coding P4ha1-203 >protein coding Contigs AC157089.5 > < AC022699.11 Regulatory Build Reverse strand 70.01 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding Ensembl protein coding merged Ensembl/Havana Page 6 of 7 https://www.alphaknockout.com Transcript: ENSMUST00000009789 50.01 kb Forward strand P4ha1-201 >protein coding ENSMUSP00000009... Low complexity (Seg) Cleavage site (Sign... Superfamily Tetratricopeptide-like helical domain superfamily SMART Prolyl 4-hydroxylase, alpha subunit Pfam Prolyl 4-hydroxylase alpha-subunit, N-terminal Oxoglutarate/iron-dependent dioxygenase PROSITE profiles Tetratricopeptide repeat-containing domain Oxoglutarate/iron-dependent dioxygenase Tetratricopeptide repeat PANTHER PTHR10869:SF101 PTHR10869 Gene3D Tetratricopeptide-like helical domain superfamily 2.60.120.620 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant stop retained variant Scale bar 0 60 120 180 240 300 360 420 534 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 7 of 7.
Load more

Recommended publications
  • 1 Supporting Information for a Microrna Network Regulates
    Supporting Information for A microRNA Network Regulates Expression and Biosynthesis of CFTR and CFTR-ΔF508 Shyam Ramachandrana,b, Philip H. Karpc, Peng Jiangc, Lynda S. Ostedgaardc, Amy E. Walza, John T. Fishere, Shaf Keshavjeeh, Kim A. Lennoxi, Ashley M. Jacobii, Scott D. Rosei, Mark A. Behlkei, Michael J. Welshb,c,d,g, Yi Xingb,c,f, Paul B. McCray Jr.a,b,c Author Affiliations: Department of Pediatricsa, Interdisciplinary Program in Geneticsb, Departments of Internal Medicinec, Molecular Physiology and Biophysicsd, Anatomy and Cell Biologye, Biomedical Engineeringf, Howard Hughes Medical Instituteg, Carver College of Medicine, University of Iowa, Iowa City, IA-52242 Division of Thoracic Surgeryh, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada-M5G 2C4 Integrated DNA Technologiesi, Coralville, IA-52241 To whom correspondence should be addressed: Email: [email protected] (M.J.W.); yi- [email protected] (Y.X.); Email: [email protected] (P.B.M.) This PDF file includes: Materials and Methods References Fig. S1. miR-138 regulates SIN3A in a dose-dependent and site-specific manner. Fig. S2. miR-138 regulates endogenous SIN3A protein expression. Fig. S3. miR-138 regulates endogenous CFTR protein expression in Calu-3 cells. Fig. S4. miR-138 regulates endogenous CFTR protein expression in primary human airway epithelia. Fig. S5. miR-138 regulates CFTR expression in HeLa cells. Fig. S6. miR-138 regulates CFTR expression in HEK293T cells. Fig. S7. HeLa cells exhibit CFTR channel activity. Fig. S8. miR-138 improves CFTR processing. Fig. S9. miR-138 improves CFTR-ΔF508 processing. Fig. S10. SIN3A inhibition yields partial rescue of Cl- transport in CF epithelia.
    [Show full text]
  • Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
    Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing
    [Show full text]
  • Oxygen-Regulated Expression of the RNA-Binding Proteins RBM3 and CIRP by a HIF-1-Independent Mechanism
    Research Article 1785 Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism Sven Wellmann1, Christoph Bührer2,*, Eva Moderegger1, Andrea Zelmer1, Renate Kirschner1, Petra Koehne2, Jun Fujita3 and Karl Seeger1 1Department of Pediatric Oncology/Hematology and the 2Department of Neonatology, Charité Campus Virchow-Klinikum, Medical University of Berlin, 13353 Berlin, Germany 3Department of Clinical Molecular Biology, Kyoto University, Kyoto 606-8507, Japan *Author for correspondence (e-mail: [email protected]) Accepted 1 December 2003 Journal of Cell Science 117, 1785-1794 Published by The Company of Biologists 2004 doi:10.1242/jcs.01026 Summary The transcriptional regulation of several dozen genes in target. In contrast, iron chelators induced VEGF but not response to low oxygen tension is mediated by hypoxia- RBM3 or CIRP. The RBM3 and CIRP mRNA increase after inducible factor 1 (HIF-1), a heterodimeric protein hypoxia was inhibited by actinomycin-D, and in vitro composed of two subunits, HIF-1α and HIF-1β. In the HIF- nuclear run-on assays demonstrated specific increases in 1α-deficient human leukemic cell line, Z-33, exposed to RBM3 and CIRP mRNA after hypoxia, which suggests that mild (8% O2) or severe (1% O2) hypoxia, we found regulation takes place at the level of gene transcription. significant upregulation of two related heterogenous Hypoxia-induced RBM3 or CIRP transcription was nuclear ribonucleoproteins, RNA-binding motif protein 3 inhibited by the respiratory chain inhibitors NaN3 and (RBM3) and cold inducible RNA-binding protein (CIRP), cyanide in a dose-dependent fashion. However, cells which are highly conserved cold stress proteins with RNA- depleted of mitochondria were still able to upregulate binding properties.
    [Show full text]
  • The Proteomic Landscape of Resting and Activated CD4+ T Cells Reveal Insights Into Cell Differentiation and Function
    International Journal of Molecular Sciences Article The Proteomic Landscape of Resting and Activated CD4+ T Cells Reveal Insights into Cell Differentiation and Function Yashwanth Subbannayya 1 , Markus Haug 1, Sneha M. Pinto 1, Varshasnata Mohanty 2, Hany Zakaria Meås 1, Trude Helen Flo 1, T.S. Keshava Prasad 2 and Richard K. Kandasamy 1,* 1 Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, 7491 Trondheim, Norway; [email protected] (Y.S.); [email protected] (M.H.); [email protected] (S.M.P.); [email protected] (H.Z.M.); trude.fl[email protected] (T.H.F.) 2 Center for Systems Biology and Molecular Medicine, Yenepoya (Deemed to be University), Mangalore 575018, India; [email protected] (V.M.); [email protected] (T.S.K.P.) * Correspondence: [email protected] Abstract: CD4+ T cells (T helper cells) are cytokine-producing adaptive immune cells that activate or regulate the responses of various immune cells. The activation and functional status of CD4+ T cells is important for adequate responses to pathogen infections but has also been associated with auto-immune disorders and survival in several cancers. In the current study, we carried out a label-free high-resolution FTMS-based proteomic profiling of resting and T cell receptor-activated (72 h) primary human CD4+ T cells from peripheral blood of healthy donors as well as SUP-T1 cells. We identified 5237 proteins, of which significant alterations in the levels of 1119 proteins were observed between resting and activated CD4+ T cells.
    [Show full text]
  • Downloaded from Ftp://Ftp.Uniprot.Org/ on July 3, 2019) Using Maxquant (V1.6.10.43) Search Algorithm
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.17.385096; this version posted November 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. The proteomic landscape of resting and activated CD4+ T cells reveal insights into cell differentiation and function Yashwanth Subbannayya1, Markus Haug1, Sneha M. Pinto1, Varshasnata Mohanty2, Hany Zakaria Meås1, Trude Helen Flo1, T.S. Keshava Prasad2 and Richard K. Kandasamy1,* 1Centre of Molecular Inflammation Research (CEMIR), and Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, N-7491 Trondheim, Norway 2Center for Systems Biology and Molecular Medicine, Yenepoya (Deemed to be University), Mangalore, India *Correspondence to: Professor Richard Kumaran Kandasamy Norwegian University of Science and Technology (NTNU) Centre of Molecular Inflammation Research (CEMIR) PO Box 8905 MTFS Trondheim 7491 Norway E-mail: [email protected] (Kandasamy R K) Tel.: +47-7282-4511 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.11.17.385096; this version posted November 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Abstract CD4+ T cells (T helper cells) are cytokine-producing adaptive immune cells that activate or regulate the responses of various immune cells.
    [Show full text]
  • Detection and Classification of Hard and Soft Sweeps from Unphased
    bioRxiv preprint doi: https://doi.org/10.1101/281063; this version posted August 15, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Detection and classification of hard and soft sweeps from unphased genotypes by multilocus genotype identity Alexandre M. Harris1;2, Nandita R. Garud3, Michael DeGiorgio1;4;5;∗ August 14, 2018 1 1 Department of Biology, Pennsylvania State University, University Park, PA 16802, USA 2 2 Program in Molecular, Cellular, and Integrative Biosciences at the Huck Institutes of the Life Sciences, 3 Pennsylvania State University, University Park, PA 16802, USA 3 4 Gladstone Institute, University of California, San Francisco, CA, 94158,USA 4 5 Department of Statistics, Pennsylvania State University, University Park, PA 16802, USA 5 6 Institute for CyberScience, Pennsylvania State University, University Park, PA 16802,USA ∗ 7 Corresponding author: [email protected] 8 Keywords: Expected haplotype homozygosity, multilocus genotype, positive selection, hard sweep, soft 9 sweep 10 Running title: Detecting hard and soft sweeps 1 bioRxiv preprint doi: https://doi.org/10.1101/281063; this version posted August 15, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Abstract 2 Positive natural selection can lead to a decrease in genomic diversity at the selected site and 3 at linked sites, producing a characteristic signature of elevated expected haplotype homozygos- 4 ity.
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands That Promote Axonal Growth
    Research Article: New Research Development Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands that Promote Axonal Growth Jeremy S. Toma,1 Konstantina Karamboulas,1,ª Matthew J. Carr,1,2,ª Adelaida Kolaj,1,3 Scott A. Yuzwa,1 Neemat Mahmud,1,3 Mekayla A. Storer,1 David R. Kaplan,1,2,4 and Freda D. Miller1,2,3,4 https://doi.org/10.1523/ENEURO.0066-20.2020 1Program in Neurosciences and Mental Health, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada, 2Institute of Medical Sciences University of Toronto, Toronto, Ontario M5G 1A8, Canada, 3Department of Physiology, University of Toronto, Toronto, Ontario M5G 1A8, Canada, and 4Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5G 1A8, Canada Abstract Peripheral nerves provide a supportive growth environment for developing and regenerating axons and are es- sential for maintenance and repair of many non-neural tissues. This capacity has largely been ascribed to paracrine factors secreted by nerve-resident Schwann cells. Here, we used single-cell transcriptional profiling to identify ligands made by different injured rodent nerve cell types and have combined this with cell-surface mass spectrometry to computationally model potential paracrine interactions with peripheral neurons. These analyses show that peripheral nerves make many ligands predicted to act on peripheral and CNS neurons, in- cluding known and previously uncharacterized ligands. While Schwann cells are an important ligand source within injured nerves, more than half of the predicted ligands are made by nerve-resident mesenchymal cells, including the endoneurial cells most closely associated with peripheral axons. At least three of these mesen- chymal ligands, ANGPT1, CCL11, and VEGFC, promote growth when locally applied on sympathetic axons.
    [Show full text]
  • Nucleic Acids Research, 2009, Vol
    Published online 2 June 2009 Nucleic Acids Research, 2009, Vol. 37, No. 14 4587–4602 doi:10.1093/nar/gkp425 An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia Yair Benita1, Hirotoshi Kikuchi2, Andrew D. Smith3, Michael Q. Zhang3, Daniel C. Chung2 and Ramnik J. Xavier1,2,* 1Center for Computational and Integrative Biology, 2Gastrointestinal Unit, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 and 3Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA Received April 20, 2009; Revised May 6, 2009; Accepted May 8, 2009 ABSTRACT the pivotal mediators of the cellular response to hypoxia is hypoxia-inducible factor (HIF), a transcription factor The transcription factor Hypoxia-inducible factor 1 that contains a basic helix-loop-helix motif as well as (HIF-1) plays a central role in the transcriptional PAS domain. There are three known members of the response to oxygen flux. To gain insight into HIF family (HIF-1, HIF-2 and HIF-3) and all are a/b the molecular pathways regulated by HIF-1, it is heterodimeric proteins. HIF-1 was the first factor to be essential to identify the downstream-target genes. cloned and is the best understood isoform (1). HIF-3 is We report here a strategy to identify HIF-1-target a distant relative of HIF-1 and little is currently known genes based on an integrative genomic approach about its function and involvement in oxygen homeosta- combining computational strategies and experi- sis.
    [Show full text]
  • SUPPLEMENTARY APPENDIX an Extracellular Matrix Signature in Leukemia Precursor Cells and Acute Myeloid Leukemia
    SUPPLEMENTARY APPENDIX An extracellular matrix signature in leukemia precursor cells and acute myeloid leukemia Valerio Izzi, 1 Juho Lakkala, 1 Raman Devarajan, 1 Heli Ruotsalainen, 1 Eeva-Riitta Savolainen, 2,3 Pirjo Koistinen, 3 Ritva Heljasvaara 1,4 and Taina Pihlajaniemi 1 1Centre of Excellence in Cell-Extracellular Matrix Research and Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Finland; 2Nordlab Oulu and Institute of Diagnostics, Department of Clinical Chemistry, Oulu University Hospital, Finland; 3Medical Research Center Oulu, Institute of Clinical Medicine, Oulu University Hospital, Finland and 4Centre for Cancer Biomarkers (CCBIO), Department of Biomedicine, University of Bergen, Norway Correspondence: [email protected] doi:10.3324/haematol.2017.167304 Izzi et al. Supplementary Information Supplementary information to this submission contain Supplementary Materials and Methods, four Supplementary Figures (Supplementary Fig S1-S4) and four Supplementary Tables (Supplementary Table S1-S4). Supplementary Materials and Methods Compilation of the ECM gene set We used gene ontology (GO) annotations from the gene ontology consortium (http://geneontology.org/) to define ECM genes. To this aim, we compiled an initial redundant set of 3170 genes by appending all the genes belonging to the following GO categories: GO:0005578 (proteinaceous extracellular matrix), GO:0044420 (extracellular matrix component), GO:0085029 (extracellular matrix assembly), GO:0030198 (extracellular matrix organization),
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,163,078 B2 Rao Et Al
    US009 163078B2 (12) United States Patent (10) Patent No.: US 9,163,078 B2 Rao et al. (45) Date of Patent: *Oct. 20, 2015 (54) REGULATORS OF NFAT 2009.0143308 A1 6, 2009 Monk et al. 2009,0186422 A1 7/2009 Hogan et al. (75) Inventors: Anjana Rao, Cambridge, MA (US); 2010.0081129 A1 4/2010 Belouchi et al. Stefan Feske, New York, NY (US); Patrick Hogan, Cambridge, MA (US); FOREIGN PATENT DOCUMENTS Yousang Gwack, Los Angeles, CA (US) CN 1329064 1, 2002 EP O976823. A 2, 2000 (73) Assignee: Children's Medical Center EP 1074617 2, 2001 Corporation, Boston, MA (US) EP 1293569 3, 2003 WO 02A30976 A1 4, 2002 (*) Notice: Subject to any disclaimer, the term of this WO O2/O70539 9, 2002 patent is extended or adjusted under 35 WO O3/048.305 6, 2003 U.S.C. 154(b) by 0 days. WO O3/052049 6, 2003 WO WO2005/O16962 A2 * 2, 2005 This patent is Subject to a terminal dis- WO 2005/O19258 3, 2005 claimer. WO 2007/081804 A2 7, 2007 (21) Appl. No.: 13/161,307 OTHER PUBLICATIONS (22) Filed: Jun. 15, 2011 Skolnicket al., 2000, Trends in Biotech, vol. 18, p. 34-39.* Tomasinsig et al., 2005, Current Protein and Peptide Science, vol. 6, (65) Prior Publication Data p. 23-34.* US 2011 FO269174 A1 Nov. 3, 2011 Smallwood et al., 2002, Virology, vol. 304, p. 135-145.* • - s Chattopadhyay et al., 2004. Virus Research, vol. 99, p. 139-145.* Abbas et al., 2005, computer printout pp. 2-6.* Related U.S.
    [Show full text]
  • Proteomics of Primary Uveal Melanoma: Insights Into Metastasis and Protein Biomarkers
    cancers Article Proteomics of Primary Uveal Melanoma: Insights into Metastasis and Protein Biomarkers Geeng-Fu Jang 1,2,†, Jack S. Crabb 1,2,†, Bo Hu 3, Belinda Willard 4, Helen Kalirai 5, Arun D. Singh 1,6, Sarah E. Coupland 5,7 and John W. Crabb 1,2,6,* 1 Cole Eye Institute, Cleveland Clinic, Cleveland, OH 44195, USA; [email protected] (G.-F.J.); [email protected] (J.S.C.); [email protected] (A.D.S.) 2 Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA 3 Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA; [email protected] 4 Proteomics and Metabolomics Facility, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA; [email protected] 5 Liverpool Ocular Oncology Research Centre, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, William Henry Duncan Building, West Derby Street, Liverpool L7 8TX, UK; [email protected] (H.K.); [email protected] (S.E.C.) 6 Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44106, USA 7 Liverpool Clinical Laboratories, Liverpool University Hospitals NHS Foundation Trust, Duncan Building, Daulby Street, Liverpool L69 3GA, UK * Correspondence: [email protected]; Tel.: +1-216-318-7298 † These two authors contributed equally to this work. Simple Summary: This study pursued the proteomic analysis of primary uveal melanoma (pUM) for insights into the mechanisms of metastasis and protein biomarkers. Liquid chromatography Citation: Jang, G.-F.; Crabb, J.S.; Hu, tandem mass spectrometry quantitative proteomic technology was used to analyze 53 metastasizing B.; Willard, B.; Kalirai, H.; Singh, A.D.; and 47 non-metastasizing pUM.
    [Show full text]